Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Clinical Associate Professor Helen Lunt

Helen Lunt 2019 imageDiabetes Physician
Clinical Director
Clinical Associate Professor

MB ChB(Brist) DM(S'ton) FRACP

Email helen.lunt@cdhb.health.nz

Christchurch Outpatients
2 Oxford Terrace
Private Bag 4710
Christchurch
New Zealand

Current Roles

  • Diabetes Physician, Christchurch Diabetes Centre
  • Clinical Director, Health Innovation Hub, Canterbury District Health Board
  • Clinical Associate Professor, University of Otago, Christchurch

Research Interests

  • Diabetes Service delivery
  • Diabetes Clinical Trials 
  • Clinical applications of diabetes technologies 

^ Top of page

Publications

Prickett, T. C. R., Lunt, H., Warwick, J., Heenan, H. F., & Espiner, E. A. (2019). Urinary amino-terminal pro-C-type natriuretic peptide: A novel marker of chronic kidney disease in diabetes. Clinical Chemistry, 65(8), 10. doi: 10.1373/clinchem.2019.306910

Lunt, H., Connor, S., Skinner, H., & Brogden, G. (2019). Electronic informed consent: The need to redesign the consent process for the digital age. Internal Medicine Journal, 49(7), 923-929. doi: 10.1111/imj.14339

Lunt, H., Heenan, H., & Chan, H. (2018). Exploring phenotype-genotype correlations using interstitial glucose results in a family with a glucokinase mutation. Journal of Diabetes Science & Technology. Advance online publication. doi: 10.1177/1932296818784064

Thompson, H., Lunt, H., Fleckney, C., & Soule, S. (2018). Insulin degludec overdose in an adolescent with type 1 diabetes: Proactive management including monitoring using the Freestyle Libre flash glucose monitoring system. Endocrinology, Diabetes & Metabolism Case Reports, 18-0044. doi: 10.1530/edm-18-0044

Lunt, H., Heenan, H. F., Edwards, P., & Florkowski, C. M. (2018). Impact of citrated blood collection tubes on red cell morphology: Implications for the measurement of plasma glucose. Clinical Chemistry & Laboratory Medicine, 56(4), 97. doi: 10.1515/cclm-2017-0790

Journal - Research Article

Prickett, T. C. R., Lunt, H., Warwick, J., Heenan, H. F., & Espiner, E. A. (2019). Urinary amino-terminal pro-C-type natriuretic peptide: A novel marker of chronic kidney disease in diabetes. Clinical Chemistry, 65(8), 10. doi: 10.1373/clinchem.2019.306910

Macdonald, C., Lunt, H., Downie, M., & Kendall, D. (2017). How satisfied are patients when their choice of funded glucose meter is restricted to a single brand? Journal of Diabetes Science & Technology, 11(5), 1001-1006. doi: 10.1177/1932296817693016

Mansell, E., Lunt, H., & Docherty, P. (2017). Laboratory diagnosis of gestational diabetes: An in silico investigation into the effects of pre-analytical processing on the diagnostic sensitivity and specificity of the oral glucose tolerance test. Clinical Biochemistry, 50(9), 506-512. doi: 10.1016/j.clinbiochem.2017.01.012

Lee, I., Lunt, H., Chan, H., Heenan, H., Berkeley, J., & Frampton, C. M. A. (2016). Postprandial capillary-venous glucose gradient in Type 1 diabetes: Magnitude and clinical associations in a real world setting. Diabetic Medicine, 33(7), 998-1003. doi: 10.1111/dme.13025

Carey, R., Lunt, H., Heenan, H. F., Frampton, C. M. A., & Florkowski, C. M. (2016). Collection tubes containing citrate stabiliser over-estimate plasma glucose, when compared to other samples undergoing immediate plasma separation. Clinical Biochemistry, 49(18), 1406-1411. doi: 10.1016/j.clinbiochem.2016.05.017

Su, H., Lunt, H., & Hoeben, K. (2016). Resilience in youth with type 1 diabetes following an earthquake. Australasian Journal of Disaster & Trauma Studies, 20(2, Spec. Iss.), 101-105. Retrieved from http://trauma.massey.ac.nz/index.html

Bergenstal, R. M., Lunt, H., Franek, E., Travert, F., Mou, J., Qu, Y., … on behalf of the IMAGINE 3 Trial Investigators. (2016). Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3. Diabetes, Obesity & Metabolism, 18(11), 1081-1088. doi: 10.1111/dom.12698

McEntyre, C. J., Lever, M., Chambers, S. T., George, P. M., Slow, S., Elmslie, J. L., Florkowski, C. M., Lunt, H., & Krebs, J. D. (2015). Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine, and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Annals of Clinical Biochemistry, 52(3), 352-360. doi: 10.1177/0004563214545346

Lunt, H., Draper, N., Marshall, H. C., Logan, F. J., Hamlin, M. J., Shearman, J. P., Cotter, J. D., … Frampton, C. M. A. (2014). High intensity interval training in a real world setting: A randomized controlled feasibility study in overweight inactive adults, measuring change in maximal oxygen uptake. PLoS ONE, 9(1), e83256. doi: 10.1371/journal.pone.0083256

Lever, M., McEntyre, C. J., George, P. M., Slow, S., Elmslie, J. L., Lunt, H., Chambers, S. T., Parry-Strong, A., & Krebs, J. D. (2014). Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. Cardiovascular Drugs & Therapy, 28, 459-468. doi: 10.1007/s10557-014-6542-9

Parwaiz, M., Lunt, H., Florkowski, C. M., Logan, F. J., Irons, L., Perwick, C., Frampton, C. M. A., & Moore, M. P. (2014). Assessment of glucose meter performance at the antenatal diabetes clinic: Exploration of patient-related and pre-analytical factors. Annals of Clinical Biochemistry, 51(1), 47-53. doi: 10.1177/0004563213487893

Chan, H., Lunt, H., Thompson, H., Heenan, H. F., Frampton, C. M. A., & Florkowski, C. M. (2014). Plasma glucose measurement in diabetes: Impact and implications of variations in sample collection procedures with a focus on the first hour after sample collection. Clinical Chemistry & Laboratory Medicine, 52(7), 1061-1068. doi: 10.1515/cclm-2013-1059

Yong, K. W., Moore, M. P., & Lunt, H. (2014). Medically facilitated discharge of adult diabetic ketoacidosis admissions: Precipitants and average length of stay. New Zealand Medical Journal, 127(1392). Retrieved from http://www.nzma.org.nz/journal

Swaminathan, A., Lunt, H., Frampton, C. M. A., & Florkowski, C. M. (2013). What is the lower limit for postprandial venous plasma glucose in healthy young adults? Annals of Clinical Biochemistry, 50(6), 614-617. doi: 10.1177/0004563213481451

Swaminathan, A., Lunt, H., Chang, W. S. J., Logan, F. J., Frampton, C. M. A., & Florkowski, C. M. (2013). Impact of prandial status on the comparison of capillary glucose meter and venous plasma glucose measurements in healthy volunteers. Annals of Clinical Biochemistry, 50(1), 6-12. doi: 10.1258/acb.2012.012084

Braatvedt, G. D., Cundy, T., Crooke, M., Florkowski, C., Mann, J. I., Lunt, H., … Drury, P. L. (2012). Understanding the new HbA1c units for the diagnosis of Type 2 diabetes [Review article]. New Zealand Medical Journal, 125(1362). Retrieved from http://www.nzma.org.nz/journal

Ellis, E., Chin, P. K. L., Hunt, P. J., Lunt, H., Lewis, J. G., & Soule, S. G. (2012). Is late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes? New Zealand Medical Journal, 125(1353). Retrieved from http://www.nzma.org.nz/journal

Krebs, J. D., Elley, C. R., Parry-Strong, A., Lunt, H., Drury, P. L., Bell, D. A., … Mann, J. I. (2012). The Diabetes Excess Weight Loss (DEWL) trial: A randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia, 55, 905-914. doi: 10.1007/s00125-012-2461-0

McLachlan, C. Y. L., Beach, R., Laing, R., Frazer, G., Lunt, H., & Cawood, T. J. (2011). Could glucose self-monitoring become the preferred tool for screening and monitoring glucose control in cystic fibrosis? Practical Diabetes International, 28(4), 173-176. doi: 10.1002/pdi.1587

Storer, M., Dummer, J., Lunt, H., Scotter, J., McCartin, F., Cook, J., Swanney, M., … Epton, M. (2011). Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes. Journal of Breath Research, 5, 046011. doi: 10.1088/1752-7155/5/4/046011

Whitehead, C., Lunt, H., Pearson, J. F., & Cawood, T. J. (2010). Is screening for hypothyroidism in the diabetes clinic effective? Practical Diabetes International, 27(3), 113-117. doi: 10.1002/pdi.1458

Ellis, E., Ballance, K., Lunt, H., & Lewis, D. (2010). Diabetes outpatient care before and after admission for diabetic foot complications. Journal of Wound Care, 19(4), 150-152.

Lunt, H., Florkowski, C., Bignall, M., & Budgen, C. (2010). Capillary glucose meter accuracy and sources of error in the ambulatory setting. New Zealand Medical Journal, 123(1310). Retrieved from http://journal.nzma.org.nz/journal/123-1308/3945/content.pdf

Doogue, M. P., Begg, E. J., Moore, M. P., Lunt, H., Pemberton, C. J., & Zhang, M. (2009). Metformin increases plasma ghrelin in Type 2 diabetes. British Journal of Clinical Pharmacology, 68(6), 875-882. doi: 10.1111/j.1365-2125.2009.03372.x

Greenslade, M. E., Lunt, H., Kendall, D., & Frampton, C. M. (2009). 'Introduction to Insulin' classes: Flexible approach to insulin initiation. Practical Diabetes International, 26(4), 142-144. doi: 10.1002/pdi.1357

Moses, R. G., Bartley, P., Lunt, H., O'Brien, R. C., Donnelly, T., Gall, M.-A., … Roberts, A. (2009). Safety and efficacy of inhaled insulin (AERx® iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from randomized, parallel group trial. Diabetic Medicine, 26(3), 260-267. doi: 10.1111/j.1464-5491.2008.02654.x

Florkowski, C., Budgen, C., Kendall, D., Lunt, H., & Moore, M. P. (2009). Comparison of blood glucose meters in a New Zealand diabetes centre. Annals of Clinical Biochemistry, 46, 302-305. doi: 10.1258/acb.2009.008193

Scott, A., Toomath, R., Bouchier, D., Bruce, R., Crook, N., Carroll, D., … Lunt, H., Wiltshire, E., & Wu, D. (2006). First national audit of the outcomes of care in young people with diabetes in New Zealand: High prevalence of nephropathy in Māori and Pacific Islanders. New Zealand Medical Journal, 119(1235). Retrieved from http://journal.nzma.org.nz/journal/119-1235/2015/content.pdf

Wu, D., Kendall, D., Lunt, H., Willis, J., Darlow, B., & Frampton, C. (2005). Prevalence of type 1 diabetes in New Zealanders aged 0-24 years. New Zealand Medical Journal, 118(1218). Retrieved from http://journal.nzma.org.nz/journal/118-1218/1557/content.pdf

Lunt, H., Kendall, D., Moore, M. P., Scott, R. S., Cole, D., Frampton, C. M., & Cullens, M. (2004). Prospective audit of conversion from regular to lispro insulin during routine clinical care. Internal Medicine Journal, 34(3), 320-323.

Wilson, M., Moore, M. P., & Lunt, H. (2004). Treatment satisfaction after commencement of insulin in Type 2 diabetes. Diabetes Research & Clinical Practice, 66, 263-267. Elsevier.

Lim, D., Lunt, H., Ojala, R., & Turner, J. (2004). Simultaneous presentation of Type 1 diabetes and thyrotoxicosis as a medical emergency [Case notes]. New Zealand Medical Journal, 117(1189). Retrieved from http://journal.nzma.org.nz/journal/117-1189/775/content.pdf

Willis, J., Scott, R. S., Darlow, B. A., Nesbit, J., Anderson, P., Moore, M. P., Lunt, H., & Cole, D. R. (2002). Incidence of type 1 diabetes mellitus diagnosed before age 20 years in Canterbury, New Zealand over the last 30 years. Journal of Pediatric Endocrinology & Metabolism, 15, 637-643.

Surgenor, L. J., Horn, J., Hudson, S. M., Lunt, H., & Tennent, J. (2000). Metabolic control and psychological sense of control in women with diabetes mellitus: Alternative considerations of the relationship. Journal of Psychosomatic Research, 49, 267-273.

Moore, M. P., & Lunt, H. (2000). Diabetes in New Zealand. Diabetes Research & Clinical Practice, 50(Suppl. 2), S65-S71.

Lunt, H., & Moore, M. P. (2000). Type 2 diabetes and tight blood pressure control: How low to go? New Zealand Medical Journal, 113, 90-91.

Kendall, D., Lunt, H., Moore, M. P., & McSweeney, W. P. (1999). Diabetes complication screening in general practice: a two pass audit with benchmarking. New Zealand Medical Journal, 112, 141-145.

Dellow, W. J., Chambers, S., Lever, M., Lunt, H., & Robson, R. A. (1999). Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia. Diabetes Research & Clinical Practice, 43(2), 91-99.

Lunt, H., Beard, M. E. J., Kendall, D., Wilson, M. A., & Frampton, C. M. (1999). Cerebrovascular disease as a general medicine discharge diagnosis: assessment of diagnostic agreement on case note review. Australian & New Zealand Journal of Medicine, 29, 319-323.

Lunt, H., Florkowski, C. M., Cundy, T., Kendall, D., Brown, L. J., Elliot, J. R., Wells, J. E., & Turner, J. G. (1998). A population-based study of bone mineral density in women with longstanding Type 1 (insulin dependent) diabetes. Diabetes Research & Clinical Practice, 40(1), 31-38. doi: 10.1016/S0168-8227(98)00012-6

Willis, J., Scott, R. S., Darlow, B. A., Lunt, H., & Moore, P. (1997). Hepatitis B immunisation and the epidemiology of IDDM in children and adolescents aged <20 years in Canterbury, New Zealand. Diabetes, 46(Suppl. 1), 140A.

Lunt, H. (1996). Women and diabetes. Diabetic Medicine, 13(12), 1009-1016.

Lunt, H., & Brown, L. J. (1996). Self-reported changes in capillary glucose and insulin requirements during the menstrual cycle. Diabetic Medicine, 13, 525-530.

^ Top of page

Journal - Research Other

Lunt, H., Connor, S., Skinner, H., & Brogden, G. (2019). Electronic informed consent: The need to redesign the consent process for the digital age. Internal Medicine Journal, 49(7), 923-929. doi: 10.1111/imj.14339

Lunt, H., Heenan, H., & Chan, H. (2018). Exploring phenotype-genotype correlations using interstitial glucose results in a family with a glucokinase mutation. Journal of Diabetes Science & Technology. Advance online publication. doi: 10.1177/1932296818784064

Lunt, H., Heenan, H. F., Edwards, P., & Florkowski, C. M. (2018). Impact of citrated blood collection tubes on red cell morphology: Implications for the measurement of plasma glucose. Clinical Chemistry & Laboratory Medicine, 56(4), 97. doi: 10.1515/cclm-2017-0790

Thompson, H., Lunt, H., Fleckney, C., & Soule, S. (2018). Insulin degludec overdose in an adolescent with type 1 diabetes: Proactive management including monitoring using the Freestyle Libre flash glucose monitoring system. Endocrinology, Diabetes & Metabolism Case Reports, 18-0044. doi: 10.1530/edm-18-0044

Heenan, H., Lunt, H., Chan, H., & Frampton, C. M. (2017). How much hemolysis is acceptable when undertaking deep lancing for finger stick derived capillary plasma glucose measurement? Journal of Diabetes Science & Technology, 11(4), 845-846. doi: 10.1177/1932296816688013

Lunt, H., & Hudson, B. (2017). Metformin: A golden oldie. New Zealand Medical Journal, 130(1465), 9-11. Retrieved from http://www.nzma.org.nz/journal

Carey, R. J., Churcher, M., Hughes, R., Florkowski, C. M., Frampton, C. M., Heenan, H. F., & Lunt, H. (2017). Will the use of lyophilized citrate tubes lead to the over-diagnosis of diabetes in pregnancy? Journal of Applied Laboratory Medicine, 1(5), 592-594. doi: 10.1373/jalm.2016.022103

More publications...